Genetic Insights into Hemiplegic Migraine: Whole Exome Sequencing Highlights Vascular Pathway Involvement via Association Analysis
Genes · 2025
DOI: 10.3390/genes16080895 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Zizi Molaee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Genomics Research Centre, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, 60 Musk Ave, Kelvin Grove, QLD 4059,…. Hauptthemen laut MEDLINE: Migraine with Aura, Cerebral Small Vessel Diseases. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHMRC, Australian National Health and Medical Research Council, Migraine Research Foundation.
Abstract (Originalsprache)
Background
Hemiplegic migraine (HM) is a rare and severe subtype of migraine with a complex genetic basis. Although pathogenic variants in CACNA1A, ATP1A2, and SCN1A explain some familial cases, a significant proportion of patients remain genetically undiagnosed. Increasing evidence points to an overlap between migraine and cerebral small vessel disease (SVD), implicating vascular dysfunction in HM pathophysiology.
Objective
This study aimed to identify rare or novel variants in genes associated with SVD in a cohort of patients clinically diagnosed with HM who tested negative for known familial hemiplegic migraine (FHM) pathogenic variants.
Methods
We conducted a case-control association analysis of whole exome sequencing (WES) data from 184 unrelated HM patients. A targeted panel of 34 SVD-related genes was assessed. Variants were prioritised based on rarity (MAF ≤ 0.05), location (exonic/splice site), and predicted pathogenicity using in silico tools. Statistical comparisons to gnomAD’s Non-Finnish European population were made using chi-square tests.
Results
Significant variants were identified in several SVD-related genes, including LRP1 (p.Thr4077Arg), COL4A1 (p.Pro54Leu), COL4A2 (p.Glu1123Gly), and TGFBR2 (p.Met148Leu and p.Ala51Pro). The LRP1 variant showed the strongest association (p < 0.001). All key variants demonstrated pathogenicity predictions in multiple computational models, implicating them in vascular dysfunction relevant to migraine mechanisms.
Conclusions
This study provides new insights into the genetic architecture of hemiplegic migraine, identifying rare and potentially deleterious variants in SVD-related genes. These findings support the hypothesis that vascular and cellular maintenance pathways contribute to migraine susceptibility and may offer new targets for diagnosis and therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genomics Research Centre, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, 60 Musk Ave, Kelvin Grove, QLD 4059, Australia.
- Genomics Research Centre, Research Infrastructure, Faculty of Sciences, Queensland University of Technology, 60 Musk Ave, Kelvin Grove, QLD 4059, Australia.
ORCID-Profile: Zizi Molaee, Neven Maksemous, Lyn R Griffiths
Förderung
- NHMRC
- Australian National Health and Medical Research Council
- Migraine Research Foundation
- Australian International Science Linkages
- Australian Government EIF Super Science Funds
- PhD scholarship provided by Queensland University of Technology
Zitieren
APA
Molaee, Z., Smith, R. A., Maksemous, N., & Griffiths, L. R. (2025). Genetic Insights into Hemiplegic Migraine: Whole Exome Sequencing Highlights Vascular Pathway Involvement via Association Analysis. Genes. https://doi.org/10.3390/genes16080895
Vancouver
Molaee Z, Smith RA, Maksemous N, Griffiths LR. Genetic Insights into Hemiplegic Migraine: Whole Exome Sequencing Highlights Vascular Pathway Involvement via Association Analysis. Genes. 2025. doi:10.3390/genes16080895
BibTeX
@article{Molaee2025,
author = {Molaee, Zizi and Smith, Robert A and Maksemous, Neven and Griffiths, Lyn R},
title = {Genetic Insights into Hemiplegic Migraine: Whole Exome Sequencing Highlights Vascular Pathway Involvement via Association Analysis},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16080895}
}
EUVIMED